Description
Retatrutide is a tri-agonist peptide that activates the GLP-1, GIP, and glucagon receptors. Its unique receptor activity has been investigated for potential impacts on metabolic functions such as energy expenditure and nutrient use. Studies suggest it may influence gastric emptying, appetite control, and the mobilization of stored energy, setting it apart from traditional GLP-1 receptor agonists through its broader mechanism of action.
RESEARCH USE ONLY
These materials are strictly intended for laboratory research and in vitro testing only. They are not approved for human consumption, medical treatment, or veterinary use. We are not associated with any pharmaceutical companies or their products. By purchasing, you confirm that these compounds will be handled solely by licensed and qualified professionals, and never introduced into humans or animals. These products are not drugs, foods, or cosmetics and must not be misrepresented, mislabeled, or used as such.
